News of the WeekDRUG SAFETY

FDA Panel Urges Caution on Many Anti-Inflammatory Drugs

Science  25 Feb 2005:
Vol. 307, Issue 5713, pp. 1183-1185
DOI: 10.1126/science.307.5713.1183a

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

GAITHERSBURG, MARYLAND-- At a 3-day meeting last week to hash out how a class of painkillers might trigger heart attacks and strokes, new puzzles emerged, even as two U.S. Food and Drug Administration (FDA) advisory committees agreed that use of the drugs be allowed but sharply curtailed.

Related Content